Baumer-Mouradian Shannon H, Collins Stacey, Lausten Thomas, Pohl Cecile, Sisney Mary, Khare Smriti, Ose Megan, Roe Jennifer, Reilly Chelsi, Gutzeit Michael
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wis.
Children's Hospital of Wisconsin, Milwaukee, Wis.
Pediatr Qual Saf. 2021 Nov 29;6(6):e532. doi: 10.1097/pq9.0000000000000532. eCollection 2021 Nov-Dec.
The COVID-19 pandemic has posed a significant threat to US healthcare workers' mental and physical health. The US Food and Drug Administration approved the first mRNA COVID-19 vaccine for Emergency Use Authorization on December 11, 2020. High-risk healthcare workers were determined to be Phase 1a. Goal: Complete the two-dose vaccine series in all interested phase 1a staff immediately after the COVID-19 vaccine was available and distributed to our institution, December 14, 2020.
A multidisciplinary team involving key stakeholders performed process mapping to develop four key drivers for vaccination success: rapid vaccine procurement, proper storage and handling, well-defined vaccine administration and follow-up plan, and system preparation. We tested interventions using plan-do-study-act cycles. We included employees and providers with direct patient care responsibilities, age 18 years or older, employed at the children's health system, or the affiliated academic medical center. We examined the total number of dose 1 and dose 2 vaccines administered for our primary outcome, and the balancing measure included the percent of wasted vaccines.
Three thousand nine-hundred twenty-one healthcare personnel completed the survey, and 73% reported intent to receive the COVID-19 vaccine immediately or at a later time. After 57 clinic days, we vaccinated 83% (n = 5,231) of healthcare personnel at our institution, and 99% completed the two-dose series. Due to surplus vaccines, we vaccinated an additional 1,258 community members with 99% completion of the two-dose series. Vaccine waste was minimal 0.1%.
We describe the development and implementation of a successful COVID-19 employee and community vaccination program.
新冠疫情对美国医护人员的身心健康构成了重大威胁。2020年12月11日，美国食品药品监督管理局批准了首款mRNA新冠疫苗用于紧急使用授权。高危医护人员被确定为1a期。目标：在2020年12月14日新冠疫苗可供使用并分发至我们机构后，立即为所有感兴趣的1a期工作人员完成两剂疫苗接种。
一个由关键利益相关者组成的多学科团队进行了流程映射，以制定疫苗接种成功的四个关键驱动因素：快速疫苗采购、妥善储存和处理、明确的疫苗接种及后续计划，以及系统准备。我们使用计划-执行-研究-行动循环测试干预措施。纳入了在儿童健康系统或附属学术医疗中心工作、年龄在18岁及以上、直接负责患者护理的员工和提供者。我们将接种的第1剂和第2剂疫苗总数作为主要结果进行检查，平衡指标包括浪费疫苗的百分比。
3921名医护人员完成了调查，73%的人表示打算立即或稍后接种新冠疫苗。经过57个门诊日，我们为机构内83%（n = 5231）的医护人员接种了疫苗，99%的人完成了两剂接种。由于疫苗有剩余，我们又为1258名社区成员接种了疫苗，两剂接种完成率为99%。疫苗浪费极少，为0.1%。
我们描述了一个成功的新冠员工及社区疫苗接种计划的制定和实施情况。
